Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
CONMED Corp
Bear Case (25th pct.)
-34.1% vs price
Base Case (Median)
-10.4% vs price
Bull Case (75th pct.)
11.4% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $41.93 | -9.5% | High (40%) |
| PE Comparable | $41.52 | -10.4% | Medium (25%) |
| Growth Trajectory DCF | $75.97 | 64.0% | Medium (20%) |
| Graham Number | $37.82 | -18.4% | Medium (40%) |
| EV/EBITDA | $23.20 | -49.9% | Medium (20%) |
| EV/FCF | $61.24 | 32.2% | Medium (20%) |
| Earnings Power Value | $7.13 | -84.6% | Medium (50%) |
Based on 7 out of 7 methods, CNMD appears fairly valued at the current price of $46.32. The base case fair value of $41.52 implies 10.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.